Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-58,023
Closed -$11M 34
2019
Q1
$11M Sell
58,023
-6,679
-10% -$1.28M 3.88% 12
2018
Q4
$12.6M Buy
64,702
+858
+1% +$167K 4.28% 4
2018
Q3
$13.2M Buy
63,844
+1,957
+3% +$386K 4.2% 4
2018
Q2
$11.4M Buy
61,887
+398
+0.6% +$70.4K 3.64% 5
2018
Q1
$10.5M Buy
61,489
+15,624
+34% +$2.87M 3.42% 7
2017
Q4
$7.98M Sell
45,865
-263
-0.6% -$46.5K 3.17% 11
2017
Q3
$8.6M Buy
46,128
+985
+2% +$175K 2.87% 16
2017
Q2
$7.78M Buy
45,143
+5,450
+14% +$886K 2.65% 14
2017
Q1
$6.51M Sell
39,693
-32,992
-45% -$5.48M 2.23% 20
2016
Q4
$10.6M Buy
+72,685
New +$10.9M 3.42% 11

Other funds holding AMGN

KDI Capital Partners's AMGN Position: Q2 2019 in Review

KDI Capital Partners sold out of Amgen (AMGN) in Q2 2019, closing a stake of 58,023 shares — an estimated $11M sold.

KDI Capital Partners first reported a position in AMGN in Q4 2016 and held it in 10 quarters. The position peaked at $13.2M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • KDI Capital Partners reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • KDI Capital Partners sold 58,023 Amgen shares in Q2 2019, an estimated $11M.
  • KDI Capital Partners first reported a position in Amgen in Q4 2016 and held it in 10 quarters.
  • KDI Capital Partners's Amgen position peaked at $13.2M in Q3 2018.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on KDI Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.